317
Views
2
CrossRef citations to date
0
Altmetric
Review

Pharmacokinetic and safety considerations when switching from standard to extended half-life clotting factor concentrates in hemophilia

&
Pages 883-892 | Received 16 Aug 2018, Accepted 15 Jul 2019, Published online: 29 Jul 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Leonard A. Valentino & Kate Khair. (2020) Prophylaxis for hemophilia A without inhibitors: treatment options and considerations. Expert Review of Hematology 13:7, pages 731-743.
Read now

Articles from other publishers (1)

Melanie Demers, Maria M. Aleman, Elena Kistanova, Robert Peters, Joe Salas & Ekta Seth Chhabra. (2022) Efanesoctocog alfa elicits functional clot formation that is indistinguishable to that of recombinant factor VIII. Journal of Thrombosis and Haemostasis 20:7, pages 1674-1683.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.